Neuland Laboratories Ltd. (NEULANDLAB) Share Price Rises 3.22% Today, Clears Large Cap Price Rise Threshold

Neuland Laboratories Ltd. Share Price Today stood at Rs 23,230.15, up 3.22%, with market capitalisation at Rs 29,446.78 crore.

Neuland Laboratories Ltd. Share Price rose to Rs 23,230.15 on 13 August 2026, up 3.22% or Rs 724.55 from the previous close of Rs 22,505.60, taking the company’s market capitalisation to Rs 29,446.78 crore. That made the stock a notable top gainer in today’s session and a stock in news within the Healthcare space. The move matters because the verified data confirms that the stock cleared the required price rise bar for its Large Cap category under the workflow’s event screen.

Today’s move also stands out because the price action was supported by a session high of Rs 23,260.85, a day open of Rs 22,819.95 and a day low of Rs 22,509.55, showing that the stock traded above the previous close for most of the session range. Turnover came in at Rs 4.67 crore, while combined exchange volume reached 94,454 shares, with 92,443 shares on NSE and 2,011 shares on BSE.

For readers searching Neuland Laboratories Ltd. Share Price Today, Neuland Laboratories Ltd. Stock News or why Neuland Laboratories Ltd. is rising today, the supplied data confirms the price event and the size of the move, but it does not establish a company-specific catalyst. What investors can track next is whether this price rise sustains through follow-through trading, how the stock compares with Healthcare sector benchmarks, and how its market capitalisation stacks up against listed peers. In this Univest stock analysis, the focus stays on verified price data, sector context and peer positioning rather than speculation.

Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 23,230.15. versus the previous close of Rs 22,505.6, a rise of 3.22%. The stock opened at Rs 22,819.95, reached Rs 23,260.85, touched Rs 22,509.55. Reported volume was 2,011.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Neuland Laboratories Ltd. Share Price is drawing attention primarily because of today’s price rise, but the most important fundamental figure supplied in this dataset is the company’s market capitalisation of Rs 29,446.78 crore. Market capitalisation does not by itself say whether a stock is expensive or inexpensive, yet it does show scale. In this case, the company sits in the Large Cap bucket within the event screen and is materially larger than the Healthcare benchmark universe averages provided in the sector data.

That scale matters when interpreting today’s move. A 3.22% increase in a company valued at Rs 29,446.78 crore represents a substantial move in market value terms compared with the same percentage move in a much smaller company. It is one reason Neuland Laboratories Ltd. Share Price News Today is relevant for investors who track large Healthcare names rather than only high-beta smaller stocks.

Trading activity also gives a useful read-through to investor attention. Turnover of Rs 4.67 crore with total volume of 94,454 shares suggests that today’s price rise was accompanied by real transaction value rather than a negligible tick. The stock opened at Rs 22,819.95 and moved to Rs 23,260.85, which indicates that the market continued to price the stock above the previous close of Rs 22,505.60 through the session.

Because the supplied dataset does not include company-specific valuation multiples, profitability ratios, earnings figures or leverage data, the most grounded fundamental context comes from scale, market positioning within the screen and how the stock compares with the broader Healthcare benchmark and listed peers on market capitalisation. That still offers useful perspective: Neuland Laboratories Ltd. Market Cap is significantly above the peer set included here, which can influence how institutions, index-aware investors and market participants monitor the stock during a day of strong price action.

From a Univest research-note perspective, the key takeaway is straightforward. The current move is notable not just because the share price rose, but because a large company in the Healthcare segment posted a verified threshold-clearing gain. That makes sector and peer context especially important when assessing how much broader attention the stock may continue to attract.

Sector and Industry Context

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector data provides the clearest benchmark for understanding where this move sits in a wider market framework. Neuland Laboratories Ltd. operates within Healthcare, and the supplied benchmark covers 196 companies in the same sector. That breadth is important because it allows investors to compare today’s price rise not just against one or two names, but against a large and varied sector universe.

Across that benchmark, the median market capitalisation is Rs 140.78 crore and the average is Rs 466.20 crore, with a minimum of Rs 3.87 crore and a maximum of Rs 3,027.48 crore. Against that backdrop, Neuland Laboratories Ltd. Market Cap of Rs 29,446.78 crore is far above both the benchmark median and average, and even substantially above the maximum market capitalisation shown in the benchmark list. That makes the company an outlier in size within the supplied Healthcare comparison set.

The sector’s valuation and profitability ranges are also wide. Based on 154 companies, the median P/E stands at 26.05 and the average P/E at 74.83, while the range extends from 3.44 to 3,374.81. For price-to-book, 195 companies show a median of 1.93 and an average of 2.59, with a minimum of -16.89 and a maximum of 16.74. Return metrics also vary materially: the median ROE is 11.07 and average ROE is 15.45, while the median ROCE is 13.35 and average ROCE is 17.79.

Those numbers matter even without a full company valuation sheet because they show how broad the Healthcare opportunity set is. Some sector names are loss-making or low-return businesses, while others trade at much richer multiples and stronger return ratios. In that context, Neuland Laboratories Ltd. Share Price Rise stands out as a large-company move inside a sector where market caps are mostly much smaller. For investors following Stock Market Today, Share Market Today or Healthcare market updates on Univest, that makes the stock’s session move more visible than a similar percentage gain in a lower-cap counter.

Peer Comparison

Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 29,446.78 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer group shows a Healthcare basket dominated by pharmaceutical and drugs companies, with one hospital and healthcare services name included. Even before looking at valuation and return metrics, the first standout point is scale. Neuland Laboratories Ltd. has a market capitalisation of Rs 29,446.78 crore, while the listed peers in the supplied set range from Rs 2,122.09 crore for Sakar Healthcare Ltd. to Rs 3,027.48 crore for Dishman Carbogen Amcis Ltd. In other words, Neuland Laboratories Ltd. is many times larger than each peer shown here.

That difference in size is significant when reading today’s Neuland Laboratories Ltd. Share Price Update. A 3.22% move in a company of this market capitalisation naturally attracts more attention from institutional desks and broader market watchers than an identical percentage move in a much smaller peer. It also means the stock’s presence in Stocks in News and Top Gainers Today screens carries a different weight.

The peer set itself shows a broad spread in fundamentals. Beta Drugs Ltd. trades at a P/E of 68.39, P/B of 10.82, ROE of 18.65% and ROCE of 22.17%, while Sai Parenteral’s Ltd. is at a P/E of 171.25 with ROE of 13.90% and ROCE of 12.97%. NGL Fine-Chem Ltd. shows ROE of 27.90% and ROCE of 33.91%, among the strongest return metrics in the set. On the other side, Dishman Carbogen Amcis Ltd. has P/B of 0.77 with ROE of -2.89% and ROCE of -0.26%, while Ind-Swift Laboratories Ltd. reports ROE of -0.78% and ROCE of 8.31%.

What this comparison shows is that the Healthcare peer basket contains both premium-valued and stressed businesses, as well as companies with very different profitability profiles. Within that landscape, Neuland Laboratories Ltd. Share Price is notable today mainly because of its scale and threshold-clearing move. The Univest view from the supplied data is not about assigning a rating; it is about recognising that this is a large-cap stock making a visible move against a diverse peer backdrop.

Why Investors Are Watching Neuland Laboratories Ltd.

Neuland Laboratories Ltd. Share Price is on investors’ radar because today’s gain was large enough to qualify under the event screen and because it came in a company with a sizeable market capitalisation relative to the broader Healthcare benchmark. The stock also held near the day’s high, which tends to keep it visible in market scans, stock updates and intraday watchlists on Univest.

• Verified price action: The stock rose 3.22%, or Rs 724.55, from Rs 22,505.60 to Rs 23,230.15.
• Intraday strength: It opened at Rs 22,819.95, touched Rs 23,260.85 and stayed above the previous close throughout the day’s range.
• Trading participation: Total volume reached 94,454 shares, including 92,443 on NSE and 2,011 on BSE, with turnover of Rs 4.67 crore.
• Scale factor: Market capitalisation at Rs 29,446.78 crore places it well above the sector benchmark averages and above the peer market-cap range supplied.
• Sector relevance: The move occurred in Healthcare, a sector benchmarked here across 196 companies with wide spreads in valuation and return ratios.

What investors may monitor next is whether Neuland Laboratories Ltd. Share Price continues to trade close to the upper end of its recent session range and whether the stock remains prominent among market movers in Healthcare. For readers using Univest for Neuland Laboratories Ltd. Stock Analysis, the combination of large-cap status, visible price action and broad peer gap in market capitalisation keeps the stock worth tracking.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. is being viewed here through the lens of the supplied market dataset, which places it in the Healthcare sector. The sector and peer mapping also shows that the nearest comparable listed names in the supplied universe are largely from Pharmaceuticals & Drugs, indicating the broad industry context in which the company is being tracked for market purposes.

That context is useful because Healthcare is not a narrow one-line sector. The benchmark includes 196 companies spanning different business models, valuation levels and profitability profiles. Some names in the supplied peer set belong to Pharmaceuticals & Drugs, while Dr Agarwals Eye Hospital Ltd. falls under Hospital & Healthcare Services. This shows that a Healthcare stock can be part of a much wider market ecosystem than a single product category.

For readers following Neuland Laboratories Ltd. Company News, Neuland Laboratories Ltd. Share News or Neuland Laboratories Ltd. Latest News, the practical takeaway is that the company is being assessed today as a significant Healthcare market participant with a market capitalisation of Rs 29,446.78 crore. That size alone sets it apart from many sector names in the supplied benchmark. In market terms, it means the stock can influence watchlists and attract broader attention when it records a sharp single-day share price gain.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow Neuland Laboratories Ltd. Share Price more closely can use Univest to track live price movement, day high and low, previous close comparisons, 52-week levels, market capitalisation trends and broader stock updates. Univest also helps users place a stock move within sector data, peer screens and market activity, which is especially useful on days when a stock enters the top gainer list.

For investors searching Neuland Laboratories Ltd. Share Price Today, Neuland Laboratories Ltd. Stock News or Neuland Laboratories Ltd. Share Price Live, the value lies in combining raw market data with structured context. That includes price action, peer comparison, sector benchmarks and ownership or technical signals whenever they are available in the verified dataset.

Frequently Asked Questions

What is Neuland Laboratories Ltd. Share Price today?

Ans. Neuland Laboratories Ltd. Share Price today was Rs 23,230.15 at the article timestamp. The stock was up Rs 724.55, or 3.22%, from the previous close of Rs 22,505.60, placing it among notable gainers in today’s session.

Why is Neuland Laboratories Ltd. rising today?

Ans. The verified data confirms that Neuland Laboratories Ltd. rose 3.22% today and cleared the event screen for a Large Cap price rise. The supplied data establishes the move and trading activity, though it does not identify a company-specific catalyst.

What was the previous close of Neuland Laboratories Ltd.?

Ans. The previous close for Neuland Laboratories Ltd. was Rs 22,505.60. Against that base, the stock gained Rs 724.55 to reach Rs 23,230.15, which translates into a 3.22% single-session increase on 13 August 2026.

What were the day high, day low and opening price?

Ans. Neuland Laboratories Ltd. opened at Rs 22,819.95, touched a day high of Rs 23,260.85 and a day low of Rs 22,509.55. This shows the stock traded in a broad intraday band while staying above the previous close.

How much volume was traded in Neuland Laboratories Ltd. today?

Ans. Total traded volume in Neuland Laboratories Ltd. stood at 94,454 shares. Of this, 92,443 shares were traded on NSE and 2,011 shares on BSE, while the turnover reported for the session was Rs 4.67 crore.

What is the market capitalisation of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. had a market capitalisation of Rs 29,446.78 crore in the supplied dataset. That places it in the Large Cap category for this event screen and makes today’s 3.22% move notable in size terms.

Which sector does Neuland Laboratories Ltd. belong to?

Ans. Neuland Laboratories Ltd. is mapped to the Healthcare sector in the supplied market data. The benchmark used for comparison covers 196 companies in the same sector, showing a wide spread in valuation, profitability and market capitalisation levels.

How does Neuland Laboratories Ltd. compare with the supplied Healthcare peers?

Ans. On market capitalisation, Neuland Laboratories Ltd. is much larger than the supplied peers. Its market cap is Rs 29,446.78 crore, while the peer set shown ranges from Rs 2,122.09 crore to Rs 3,027.48 crore.

What does the Healthcare sector benchmark show?

Ans. The Healthcare benchmark covers 196 companies. It shows a median P/E of 26.05, average P/E of 74.83, median P/B of 1.93, average ROE of 15.45 and average ROCE of 17.79, highlighting broad variation across the sector.

Why are investors tracking Neuland Laboratories Ltd. Stock News today?

Ans. Investors are tracking Neuland Laboratories Ltd. Stock News because the stock rose 3.22%, held near its intraday high of Rs 23,260.85 and did so with a market capitalisation of Rs 29,446.78 crore, making it a visible large-cap mover.